Replies to post #827319 on NorthWest Biotherapeutics Inc (NWBO)

[bakum]

think what you want but "hundreds of PRs have produced nothing but smoke and mirrors" is demonstrably false. It's vibes.

[FrostyIsland3]

We know the fo0llowing:

1. OHEAG reviewed the DCVax-L MAA on June 20, 2024.
2. CHM reviewed the DCVax-L MAA on June 27-28, 2024 and issued an RFI to NWBO.
3. OHEAG probably reviewed DCVax-L for a second time on November 20, 2025.
4. CHM reviewed DCVax-L MAA for a second time on November 27-28, 2025, and advised MHRA about DCVax-L.
5. MHRA issued an MIA investigational medicine manufacturing license to NWBO on December 15, 2025.
6. MHRA issued an MIA commercial manufacturing license to NWBO on April 22, 2025.
7. The MHRA has publicly responded twice to Parliament regarding the ongoing DCVax-L MAA on December 8, 2025 and March 18, 2026.

These are all independently verifiable from the UK government and are not dependent upon NWBO describing these events.